R1 RCM Inc. (NASDAQ:RCM – Get Free Report) has received an average rating of “Moderate Buy” from the twelve analysts that are currently covering the stock, MarketBeat.com reports. One research analyst has rated the stock with a hold recommendation and eleven have assigned a buy recommendation to the company. The average twelve-month price objective among […]
Royal Bank of Canada restated their outperform rating on shares of R1 RCM (NASDAQ:RCM – Free Report) in a research note released on Thursday, Benzinga reports. They currently have a $19.00 target price on the healthcare provider’s stock. A number of other equities analysts also recently weighed in on the company. KeyCorp dropped their target […]
R1 RCM (NASDAQ:RCM – Get Free Report)‘s stock had its “buy” rating restated by Canaccord Genuity Group in a research note issued to investors on Thursday, Benzinga reports. They currently have a $17.00 price objective on the healthcare provider’s stock. Canaccord Genuity Group’s target price would suggest a potential upside of 60.23% from the stock’s […]
Shares of R1 RCM Inc. (NASDAQ:RCM – Get Free Report) have been given an average rating of “Moderate Buy” by the twelve research firms that are presently covering the stock, Marketbeat.com reports. One investment analyst has rated the stock with a hold recommendation and eleven have assigned a buy recommendation to the company. The average […]
Shelton Capital Management bought a new stake in R1 RCM Inc. (NASDAQ:RCM – Free Report) in the second quarter, according to its most recent Form 13F filing with the SEC. The institutional investor bought 217,094 shares of the healthcare provider’s stock, valued at approximately $4,005,000. Shelton Capital Management owned 0.05% of R1 RCM as of […]